Intellia Therapeutics to Present at Baird’s 2020 Virtual Global Healthcare Conference
02 Septembre 2020 - 2:00PM
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing
company focused on developing curative therapeutics using
CRISPR/Cas9 technology both in vivo and ex vivo, will present at
Baird’s 2020 Virtual Global Healthcare Conference on Wednesday,
September 9, 2020 at 10:50 a.m. ET.
A live webcast of Intellia’s presentation will be accessible
through the Events and Presentations page of the Investors &
Media section of the company’s website at www.intelliatx.com. To
access the webcast, please log on approximately 15 minutes prior to
the start time, to ensure adequate time for any software downloads
that may be required. A replay of the webcast will be available on
Intellia’s website for approximately 14 days following the live
event. About Intellia TherapeuticsIntellia
Therapeutics is a leading genome editing company focused on
developing proprietary, curative therapeutics using the CRISPR/Cas9
system. Intellia believes the CRISPR/Cas9 technology has the
potential to transform medicine by permanently editing
disease-associated genes in the human body with a single treatment
course, and through improved cell therapies that can treat cancer
and immunological diseases, or can replace patients’ diseased
cells. The combination of deep scientific, technical and clinical
development experience, along with its leading intellectual
property portfolio, puts Intellia in a unique position to unlock
broad therapeutic applications of the CRISPR/Cas9 technology and
create a new class of therapeutic products. Learn more about
Intellia Therapeutics and CRISPR/Cas9 at intelliatx.com and follow
us on Twitter @intelliatweets.
Intellia Contacts:
Investors:Lina LiAssociate DirectorInvestor
Relations+1 857-706-1612lina.li@intelliatx.com
Media:Jennifer Mound SmoterSenior Vice
PresidentExternal Affairs & Communications+1
857-706-1071jenn.smoter@intelliatx.com
Intellia Therapeutics (NASDAQ:NTLA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Intellia Therapeutics (NASDAQ:NTLA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024